跳至主要内容
临床试验/NCT04401787
NCT04401787已完成不适用

Is There Better Oncological and Short Term Outcome for Laparoscopic Resection of Upper Rectal Carcinoma T1-4 N0-1 Over Laparoscopic Converted Cases in Obese Patients?

Zagazig University0 个研究点目标入组 156 人开始时间: 2016年12月11日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
156
主要终点
hospital stay-perioperative length

研究概览

简要总结

Background: laparoscopic resection (LAR) is a safe approach and widely used for rectal cancer after neoadjuvant chemo-radiotherapy, but short term and oncological outcome for converted cases to open surgery (cLAR), may be questioned in an obese patient.

Objective: validating the short-term and oncological outcomes after laparoscopic resection and after conversion to open surgery for upper rectal cancer in obese patients.

Patients and methods: A prospective study included 191 patients, randomly allocated into two arms of the study, Arm I is open anterior resection (OAR), this is the control and arm II, The LAR. Only 156 analyzed.

详细描述

Study design: A randomized control study assigned to involve obese patients with BMI 30 diagnosed with upper rectal carcinoma T1-4 N0-1, 181 patients assigned into two arms and operated in multi-centres in a tertiary hospitals.

Ethical approval and clinical registration: Our study was submitted, revised and finally permitted and approved by the Institutional Review Board of the Zagazig University hospital, faculty of medicine, holding number IR-20780302-1, and informed consent was obtained from all participants agreed to be involved. Study registered in ClinicalTrial.gove: ID: .........

Protocol and setting:

A study was done in the period from December 2016 to December 2019 and data registered after each procedure in our database system The controlled arm included patients underwent open anterior resection (OAR) for upper rectal carcinoma and divided into Ia, underwent OAR and IIa, included patients with cLAR, whereas Group II included patients underwent LAR.

Method of randomization:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
26 Years 至 74 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Obese patients with BMI ≥27 with operable upper rectal carcinoma staged T1-4 N0-1 based on colonoscopy, endo-rectal ultrasound, CT abdomen and pelvis and MRI abdomen

排除标准

  • •BMI less than 27, According to AJCC TNM staging 7th edition, N2-3 patients were excluded, any evidence of inoperability whether distant metastasis or invasive tumours, Patients with synchronous colorectal tumours, synchronous liver metastasis obstructive symptomatic patients and patients with intraoperative tumour rupture or perforation, rectal tumours below peritoneal reflection

研究组 & 干预措施

laparoscopic anterior resection (LAR)

Active Comparator

LAR group included 88 patients, 17 patients converted to open

干预措施: Anterior resection for upper rectal cancer in obese (Procedure)

open anterior resection

Active Comparator

Open anterior resection for 56 patients

干预措施: Anterior resection for upper rectal cancer in obese (Procedure)

结局指标

主要结局

hospital stay-perioperative length

时间窗: up to 3 years

recovery time-intraoperative bleeding

时间窗: up to 3 years

Incidence of wound infection

时间窗: up to 3 years

oncological outcome

时间窗: 3 years

total mesorectal excision, margin included or not

次要结局

  • early locoregional recurrence(6 months)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Bassem Mohamed Sieda

Assistant professor of general surgery

Zagazig University

相似试验